Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study

Nina Friis-Møller, Rodolphe Thiébaut, Peter Reiss, Rainer Weber, Antonella D'Arminio Monforte, Stephane De Wit, Wafaa El-Sadr, Eric Fontas, Signe Westring Worm, Ole Kirk, Andrew Phillips, Caroline A Sabin, Jens D Lundgren, Matthew G Law, DAD study group

314 Citationer (Scopus)

Abstract

HIV-infected patients receiving combination antiretroviral therapy may experience metabolic complications, potentially increasing their risk of cardiovascular diseases (CVDs). Furthermore, exposures to some antiretroviral drugs seem to be independently associated with increased CVD risk. We aimed to develop cardiovascular risk-assessment models tailored to HIV-infected patients.

Fingeraftryk

Dyk ned i forskningsemnerne om 'Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study'. Sammen danner de et unikt fingeraftryk.

Citationsformater